Zeo ScientifiX (ZEOX) Current Deferred Revenue (2015 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Current Deferred Revenue of $671000.0 for Q2 2026, down 21.61% year-over-year from $856000.0 in Q2 2025, and up 5.84% quarter-over-quarter from $634000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Current Deferred Revenue (2015 - 2026) Analysis & Trends
Zeo ScientifiX's Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $671000.0 for Q2 2026.
- In Q2 2026, Current Deferred Revenue fell 21.61% year-over-year to $671000.0; the TTM figure through Apr 2026 stood at $671000.0 (down 21.61% YoY), while the FY2025 annual figure was $598000.0, down 32.35% from the prior year.
- Current Deferred Revenue for Q2 2026 stood at $671000.0, up from $634000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.1 million in Q3 2024, with the low at $4195.0 in Q1 2023.
- The 4-year median for Current Deferred Revenue is $690000.0 (2025), against an average of $608361.4.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue soared 19208.7% in 2024, then tumbled 35.84% in 2025.
- Zeo ScientifiX's Current Deferred Revenue stood at $497000.0 in 2023, then surged by 77.87% to $884000.0 in 2024, then sank by 32.35% to $598000.0 in 2025, then gained by 12.21% to $671000.0 in 2026.
- Business Quant data shows ZEOX's Current Deferred Revenue at $671000.0 in Q2 2026, $634000.0 in Q1 2026, and $598000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 671,000.00 |
| Jan 31, 2026 | 634,000.00 |
| Oct 31, 2025 | 598,000.00 |
| Jul 31, 2025 | 709,000.00 |
| Apr 30, 2025 | 856,000.00 |
| Jan 31, 2025 | 900,000.00 |
| Oct 31, 2024 | 884,000.00 |
| Jul 31, 2024 | 1.11 Mn |
| Apr 30, 2024 | 792,000.00 |
| Jan 31, 2024 | 810,000.00 |
| Oct 31, 2023 | 497,000.00 |
| Jul 31, 2023 | 32,660.00 |
| Apr 30, 2023 | 24,204.00 |
| Jan 31, 2023 | 4,195.00 |
| Oct 31, 2021 | 9,575.00 |
| Jul 31, 2019 | 5,840.00 |
| Apr 30, 2019 | 5,840.00 |
| Jan 31, 2019 | 5,840.00 |
| Oct 31, 2018 | 21,520.00 |
| Jan 31, 2018 | 11,965.00 |